GENERATION OF MCHERRYBODY: AN ANTI-TRANSFERRIN RECEPTOR ANTIBODY VARIABLE FRAGMENT LINKED BY THE MCHERRY FLUORESCENT PROTEIN

被引:0
|
作者
Kusharyoto, Wien [1 ]
Andriani, Dian [1 ]
Handayani, Ira [1 ]
机构
[1] Indonesian Inst Sci LIPI, Res Ctr Biotechnol, Lab Appl Genet Engn & Prot Design, Cibinong Sci Ctr, Jalan Raya Bogor KM 46, Bogor 16911, Indonesia
关键词
antibody variable fragment; fluorescent protein; molecular design; mCherry; transferrin receptor;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A facile generation of a recombinant antibody fragment with intrinsic fluorescent properties of the monomeric mCherry fluorescent protein is described. The so-called mCherryBody was designed based on the structure model of the variable fragment of anti-transferrin receptor antibody LUCA31 and the X-ray crystallographic structure of the mCherry protein. mCherryBody was constructed to retain optimal spatial geometry between the C-and N-termini of the antibody light-chain (V-L) and heavy-chain (V-H) by mimicking the domains interface pairing in antibody Fab fragments and incorporation of the mCherry fluorescent protein as a bridging scaffold. The gene encoding the chimeric protein was cloned into the pJExpress414 expression vector, expressed and secreted into the periplasm of Escherichia coli NiCo21(DE3) for assembly and disulphide bond formation. Based on its amino acid sequence, mCherryBody was predicted to have a molecular weight of 51.46 kDa. The modular assembly used in the generation of mCherryBody may permit the interchange of binding sites and of fluorescent proteins to create robust panels of coloured antibody fragments. Thus, the mCherryBody platform facilitates rapid generation of colored single-chain variable fragment (scFv) chimeras that could be used for screening of antibodies against cell surface markers or receptors.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 50 条
  • [21] Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody
    C Callens
    I C Moura
    Y Lepelletier
    S Coulon
    A Renand
    M Dussiot
    D Ghez
    M Benhamou
    R C Monteiro
    A Bazarbachi
    O Hermine
    Leukemia, 2008, 22 : 42 - 48
  • [22] Restricted transport of anti-transferrin receptor antibody (OX26) through the blood-brain barrier in the rat
    Moos, T
    Morgan, EH
    JOURNAL OF NEUROCHEMISTRY, 2001, 79 (01) : 119 - 129
  • [23] Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody
    Callens, C.
    Moura, I. C.
    Lepelletier, Y.
    Coulon, S.
    Renand, A.
    Dussiot, M.
    Ghez, D.
    Benhamou, M.
    Monteiro, R. C.
    Bazarbachi, A.
    Hermine, O.
    LEUKEMIA, 2008, 22 (01) : 42 - 48
  • [24] A chimera of green fluorescent protein with single chain variable fragment antibody against ginsenosides for fluorescence-linked immunosorbent assay
    Sakamoto, Seiichi
    Tanizaki, Yusuke
    Pongkitwitoon, Benyakan
    Tanaka, Hiroyuki
    Morimoto, Satoshi
    PROTEIN EXPRESSION AND PURIFICATION, 2011, 77 (01) : 124 - 130
  • [25] An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human non-hematopoietic tumor cells
    Shen, Xin
    Zhu, Hui-fen
    He, Feng-rong
    Xing, Wei
    Li, Li
    Liu, Jing
    Yang, Juan
    Pan, Xing-fei
    Lei, Ping
    Wang, Zhi-hua
    Shen, Guan-xin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (13-14) : 1813 - 1820
  • [26] Role of macrophages in the antitumor activity of an anti-transferrin receptor 1 antibody ch128.1 in a xenograft model of multiple myeloma
    Leoh, Lai Sum
    Kim, Yoon Kyung
    Candelaria, Pierre V.
    Martinez-Maza, Otoniel
    Daniels-Wells, Tracy R.
    Penichet, Manuel L.
    CANCER RESEARCH, 2017, 77
  • [27] Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief Communication
    Daniels-Wells, Tracy R.
    Widney, Daniel P.
    Leoh, Lai Sum
    Martinez-Maza, Otoniel
    Penichet, Manuel L.
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (08) : 307 - 310
  • [28] Interim Phase I Safety Study of Anti-Transferrin Receptor Antibody(PPMX-T003) in Patients with Polycythemia Vera
    Ito, Tomoki
    Takakuwa, Teruhito
    Hino, Masayuki
    Nakamae, Hirohisa
    Matsuura, Tadashi
    BLOOD, 2023, 142
  • [29] Pharmacokinetics and blood-brain barrier transport of an anti-transferrin receptor monoclonal antibody (OX26) in rats after chronic treatment with the antibody
    Wu, DF
    Pardridge, WM
    DRUG METABOLISM AND DISPOSITION, 1998, 26 (09) : 937 - 939
  • [30] Trafficking of Gold Nanoparticles Coated with the 8D3 Anti-Transferrin Receptor Antibody at the Mouse Blood-Brain Barrier
    Cabezon, Itsaso
    Manich, Gemma
    Martin-Venegas, Raquel
    Camins, Antoni
    Pelegri, Carme
    Vilaplana, Jordi
    MOLECULAR PHARMACEUTICS, 2015, 12 (11) : 4137 - 4145